Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
BioCryst Pharmaceuticals, Inc. is a biotechnology company focused on developing and commercializing medicines for hereditary angioedema (HAE) and other rare diseases. Its marketed products include oral, once-daily ORLADEYO for the prevention of HAE attacks and RAPIVAB (peramivir injection) for the treatment of acute uncomplicated influenza in the United States. Its other products and product candidates include BCX17725, navenibart, Avoralstat, STAR-0310, RAPIACTA (peramivir injection) and PERAMIFLU (peramivir injection). The RAPIVAB (peramivir injection) is approved in the United States for the treatment of acute uncomplicated influenza for patients six months and older. Peramivir injection is also approved in Canada (RAPIVAB), Australia (RAPIVAB), Japan (RAPIACTA), Taiwan (RAPIACTA), and Korea (PERAMIFLU). It has also obtained an early-stage program for atopic dermatitis (AD), STAR0310.
Find out what a historical investment in Biocryst Pharmaceuticals Inc would be worth today using our BCRX stock calculator.
Buying BCRX shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Biocryst Pharmaceuticals Inc in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in BCRX
What is the ticker symbol of Biocryst Pharmaceuticals Inc?
The ticker symbol for Biocryst Pharmaceuticals Inc is BCRX.
How much is one share of BCRX?
One share of BCRX is valued at $7.22 as of 22 November 2026.
What is the market capitalisation of Biocryst Pharmaceuticals Inc BCRX?
As of 22 November 2026 Biocryst Pharmaceuticals Inc has a market cap of $1.86B.
What is the 52-week high for Biocryst Pharmaceuticals Inc stock?
The Biocryst Pharmaceuticals Inc 52-week high stock price is $11.22.
What is the 52-week low for Biocryst Pharmaceuticals Inc stock?
The Biocryst Pharmaceuticals Inc 52-week low stock price is $6.23.
Can I buy BCRX shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy BCRX shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in BCRX on Stake
Buy BCRX from US$3 brokerage
Invest in 11,000+ U.S. stocks and ETFs
Own a slice of BCRX from only US$10 with fractional shares